The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
Chakera, Ali J.
Hattersley, Andrew T.
Dunne, F. P.
Research Support, Non-U.S. Gov't
PublisherAmerican Diabetes Association
RightsArchived with thanks to Diabetes care
MetadataShow full item record
Identifying glucokinase monogenic diabetes (GCK-MODY) in pregnancy is important, as management is different from management for other forms of gestational diabetes mellitus (GDM) and there is no increased maternal risk of type 2 diabetes. We calculated the population prevalence of GCK-MODY in pregnancy and determined the clinical characteristics that differentiate pregnant women with GCK-MODY from those with GDM.